Consensus Abbott Laboratories

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 04:04:03 2026-10-21 pm EDT			Pre-market 07:45:52 am
100.51 ^USD	-1.89%		100.61	+0.10%

07:02am	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
05:58am	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

303f5469acc74ca5df6a0e7.tiPfTt_gtZlsuTZmENvq4j3VT4I4NcLceybb_qSU8ig._W6KGoaOgrQVlFokIbaIiAicLdFQUfupFnmdh_ynkxDpRKwPro7doBnTUQ~2155e5316ad86467a18332f0cc2c14c1

Analysts' recommendations: Abbott Laboratories

07:02am	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
05:58am	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT
05:57am	BTIG Adjusts Price Target on Abbott Laboratories to $125 From $134	MT
05:57am	Wells Fargo Adjusts Price Target on Abbott Laboratories to $119 From $112	MT
05:56am	JPMorgan Adjusts Price Target on Abbott Laboratories to $118 From $120	MT
05:56am	TD Cowen Adjusts Price Target on Abbott Laboratories to $118 From $135	MT
Oct. 20	Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says	MT
Oct. 07	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
Oct. 05	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
Oct. 02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
Oct. 02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
Oct. 02	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
Aug. 21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
Aug. 13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
Aug. 13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
Jul. 28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
Jul. 28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
Jul. 23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
Jul. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
Jul. 17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
Jul. 17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
Jul. 17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
Jul. 17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
Jul. 17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
Jul. 17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+18.95%
	STRYKER CORPORATION					+21.85%
	MEDTRONIC PLC					+12.45%
	ESSILORLUXOTTICA					+23.1%
	CENCORA, INC.					+8.42%
	HOYA CORPORATION					+15.54%
	BECTON, DICKINSON AND COMPANY					+0.63%
	IDEXX LABORATORIES, INC.					+26.11%
	ALCON INC.					+33.74%
	MEDLINE INC.					+25.81%
	Average					+18.66%
	Weighted average by Cap.					+17.82%